ArticleThe oncologist2018

Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab.

Yukihiro Toi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.